Skip to main content
. 2023 Jan 30;162(3):461–469. doi: 10.1007/s11060-023-04250-5

Table 3.

Grading criteria for astrocytomas, IDH-mutant

CNS WHO grade Criteria
2 Well differentiated and lacks histological features of anaplasia
Mitotic activity is not detected or very low
Microvascular proliferation, necrosis, and homozygous deletions of CDKN2A and/or CDKN2B are absent
3 Focal or dispersed anaplasia
Significant mitotic activity
Microvascular proliferation, necrosis, and homozygous deletions of CDKN2A and/or CDKN2B are absent
4 Microvascular proliferation, necrosis or homozygous deletion of CDKN2A and/or CDKN2B